ROR1 and precursor B-cell acute lymphoblastic leukemia: To investigate the utility of ROR1 as a target for mAb therapy of pediatric B-ALL, we analyzed cell surface ROR1 expression across ALL subtypes and in normal adult and pediatric tissues.